XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.22

-5.0%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kushi Kullar who wrote (8568)	2/1/1999 8:04:00 PM
From: Bluegreen	Read Replies (2) of 17367

Kushi, I can't think of any other company this close to possible approval of a natural antimicrobial peptide. Key word is antimicrobial. If we had an article like ENMD did not too long ago in the New York times, well, in my opinion, you go straight to 100 bucks a share in this kind of feeding frenzy market. Also, Xoma is always in danger of being bought out. Now the downside risk is XOMA could go bankrupt on you and you could lose all your money. And of course the third scenario is like your SCIOS example, nothing happens even after approval and plenty of time to buy in. My plan is being in the stock some now and put the pedal to the metal if approval comes. I watch this stock daily. Only my opinions.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next